Silvercrest Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Silvercrest Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-141,515	Closed	-$10.2M	–	903
2020 Q4	$10.2M	Buy	141,515 +19,910	+16%	+$1.04M	0.07%	240
2020 Q3	$5.54M	Sell	121,605 -2,129	-2%	-$89K	0.05%	321
2020 Q2	$5.59M	Sell	123,734 -2,306	-2%	-$103K	0.05%	293
2020 Q1	$4.85M	Sell	126,040 -20,802	-14%	-$958K	0.05%	281
2019 Q4	$6.8M	Sell	146,842 -6,262	-4%	-$271K	0.05%	289
2019 Q3	$6.24M	Buy	+153,104	New	+$6.61M	0.05%	288

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Silvercrest Asset Management's BEAT Position: Q1 2021 in Review

Silvercrest Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 141,515 shares — an estimated $10.2M sold.

Silvercrest Asset Management first reported a position in BEAT in Q3 2019 and held it in 6 quarters. The position peaked at $10.2M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Silvercrest Asset Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Silvercrest Asset Management sold 141,515 BioTelemetry, Inc. shares in Q1 2021, an estimated $10.2M.
Silvercrest Asset Management first reported a position in BioTelemetry, Inc. in Q3 2019 and held it in 6 quarters.
Silvercrest Asset Management's BioTelemetry, Inc. position peaked at $10.2M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Silvercrest Asset Management's 13F filing for Q1 2021, filed 17 May 2021.